PMV is a biotechnology company dedicated to selectively targeting mutant p53, providing unique therapies for any patient whose tumor harbors these gene mutations.
For more details on financing and valuation for PMV Pharma, register or login.
By registering, you agree to Forge’s Terms of Use. Already registered? Log in
PMVP
4.86 as of 3/28/23
To read this article and more news on PMV Pharma, register or login.
